DE HB309 | 2021-2022 | 151st General Assembly
Status
Completed Legislative Action
Spectrum: Slight Partisan Bill (Democrat 16-10)
Status: Passed on August 4 2022 - 100% progression
Action: 2022-08-04 - Signed by Governor
Text: Latest bill text (Draft #1) [HTML]
Spectrum: Slight Partisan Bill (Democrat 16-10)
Status: Passed on August 4 2022 - 100% progression
Action: 2022-08-04 - Signed by Governor
Text: Latest bill text (Draft #1) [HTML]
Summary
This Act, modeled on similar laws in Virginia and Maryland, requires a health-care provider to provide notice to a patient at the time blood is drawn to perform a laboratory test for Lyme disease that explains the limitations of the test and instructs the patient to see their health-care provider if the patient continues to experience unexplained symptoms. This Act was previously passed by the 150th General Assembly in Senate Bill 15, and is the same except for the removal of the sunset provision.
Title
An Act To Amend Title 16 Of The Delaware Code Relating To The Provision Of Information About Lyme Disease.
Sponsors
Roll Calls
2022-06-30 - Senate - Senate Third Reading (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2022-03-17 - House - House Third Reading (Y: 41 N: 0 NV: 0 Abs: 0) [PASS]
2022-03-17 - House - House Third Reading (Y: 41 N: 0 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2022-08-04 | Signed by Governor | |
2022-06-30 | Passed By Senate. Votes: 21 YES | |
2022-04-06 | Reported Out of Committee (Health & Social Services) in Senate with 5 Favorable, 1 On Its Merits | |
2022-03-17 | Assigned to Health & Social Services Committee in Senate | |
2022-03-17 | Passed By House. Votes: 41 YES | |
2022-03-16 | Reported Out of Committee (Health & Human Development) in House with 9 Favorable, 3 On Its Merits | |
2022-03-03 | Introduced and Assigned to Health & Human Development Committee in House |